AMN Healthcare Services 2026 Q3 Earnings Call
Review the key takeaways and the transcript of this earnings call.
- AMN Healthcare reported 3rd quarter 2026 revenue of $717 million, up 13% year over year and 7% sequentially; revenue grew 6% excluding labor disruption activities.
- Net income was $33 million, or $0.83 per share, adjusted EBITDA was $94 million, or 13% of revenue, and adjusted EPS was $1.16.
- Results included a $51 million favorable reserve adjustment for past labor disruption events; the adjustment increased reported gross margin by 520 basis points.
- Nurse and Allied revenue was $460 million, up 27% year over year including labor disruption activity and up 15% excluding it; travel nurse volume increased 21% and Allied volume increased 12%.
- Physician and Leadership Solutions revenue was $171 million, down 4% year over year; Locum Tenens revenue was $138 million, down 5% year over year, while Search revenue grew 15%.
- Technology and Workforce Solutions revenue was $86 million, down 9% year over year; Language Services revenue was $69 million, down 8%, and BMS revenue was $15 million, down 11%.
- AMN ended the quarter with $256 million in cash and equivalents and $750 million in total debt; its credit-agreement leverage ratio was 1.3 times.
STOCKNOW INSIGHTS
Continue with outlook and guidance.
Log in to unlock executive comments and Q&A highlights.
Log in for the full summaryStockNow uses AI to translate and summarize earnings calls. Accuracy and completeness are not guaranteed.
Transcript
Preview the first fifteen paragraphs, organized by speaker.
Good afternoon, ladies and gentlemen, and welcome to the AMN Healthcare Third Quarter 2026 Earnings Conference Call. At this time, all lines are in listen-only mode. Following the presentation, we will conduct a question-and-answer session. If at any time during this call you require immediate assistance, please press star zero for the operator. This call is being recorded on Thursday, November 5th of 2026. I would now like to turn the conference over to Randy Reece, Vice President of Investor Relations.
Please go ahead. Good afternoon, everyone.
Welcome to AMN Healthcare's Third Quarter 2026 Earnings Call. A replay of this webcast will be available at ir.amnhealthcare.com at the conclusion of this call. Remarks we make during this call about future expectations, projections, trends, plans, events, or circumstances constitute forward-looking statements. These statements reflect the company's current beliefs based upon information currently available to it. Our actual results may differ materially from those indicated by these forward-looking statements because of various factors and cautionary statements, including those identified in our most recently filed forms 10-K and 10-Q, our earnings release, and subsequent filings with the SEC. The company does not intend to update guidance or any forward-looking statements provided today prior to its next earnings release. This call contains certain non-GAAP financial information.
Information regarding and reconciliations of these non-GAAP measures to the most directly comparable GAAP measures are included in our earnings release and on our financial reports page at ir.amnhealthcare.com. On the call with me today are Cary Grace, President and Chief Executive Officer, and Brian Scott, Chief Financial and Operating Officer. I will now turn the call over to Cary.
AMN continued to deliver on our mission of empowering the future of care as reflected in our third quarter results. Revenue of $717 million grew 13% year-over-year, or 6% excluding labor disruption activities. Nurse and Allied segment revenue grew 27% from a year ago, or 15% without labor disruption. Search revenue saw 15% year-over-year revenue growth. Net income for the third quarter was $33 million, or $0.83 per share, and adjusted EBITDA was $94 million. Third quarter results included a $51 million favorable reserve adjustment for past labor disruption events. We see healthcare organizations taking a broader view of their workforce. While clients remain focused on cost and flexibility, increasingly they want better insights and visibility into demand, supply, and performance across their workforce. That plays to AMN's strengths.
Our combination of talent depth, trusted client relationships, operational expertise, and technology-enabled solutions allows us to help clients not simply fill positions, but also make better workforce decisions. Underlying demand in most of our businesses continued to grow, and our teams executed well against this demand. Third quarter performance benefited from the market uplift, along with our company-specific gains in candidate acquisition and placements across sales channels. Five of our businesses have returned to year-over-year growth, and we see a path for the remaining businesses to return to growth in 2027. We are particularly encouraged by the growth in our Nurse and Allied business. Demand has strengthened, and our teams are capturing that demand through the improvements we have made in AI recruiting, speed, and 24/7 execution. We still view core staffing demand as the bellwether for long-term growth in our total addressable market.
We hear common themes from our network of 2,300 clients, which includes some of the country's largest health systems. The most prevalent drivers of travel staffing demand are growth in patient volume and persistent vacancies and turnover in core staff positions. Across healthcare, permanent hiring has slowed to a level of little more than one-to-one parity with attrition. Many healthcare leaders recognize the flexibility and cost-effectiveness of our total talent solutions. The cost premium for travelers over the all-in cost of permanent clinical staff is at a historic low. Improved demand boosted third quarter revenue for Nurse and Allied to $460 million. Volume was 16% higher than a year ago, including 21% growth in travel nurse and a 12% increase for allied. The average number of nurse and allied travelers in the third quarter was 3% higher than Q2, defying typical seasonality.
Our education volume is up over 25% year over year. Nursing and allied demand increased by 70% from the low point in February through October. While demand and volume have grown, gross margins are holding relatively stable from a combination of flat bill rates and a market that remains highly competitive. Though we have seen healthy increases in supply, we are beginning to see clinicians hold out for higher rates. Historically, this dynamic has led to increased pricing, which would be a positive for margin and operating leverage in the future. Offsetting some of the strength in short-term nurse is our international nurse business, where ongoing delays in embassy visa appointments will result in near-term headwinds for the business. We have very recently seen some appointments come through, but they have been limited, and we expect the slowdown to constrain placements in 2027 until appointments return to more normalized levels.
In the fourth quarter, we project Nurse and Allied revenue to be down 13%-15% year over year, with labor disruption revenue being $5 million this quarter compared with $124 million in Q4 2025. Excluding labor disruption, Nurse and Allied revenue is projected to grow 13%-15% year over year. Our international business is expected to be down in the low teens sequentially, though still achieving high single-digit year-over-year growth. Physician and Leadership Solutions revenue was $171 million in the third quarter, down 4% year over year, though 4% higher sequentially. Locum tenens revenue of $138 million was up 6% sequentially and down 5% year over year. The 15% growth in search reflects particular strength in executive search and physician permanent placement.
Our executive and interim search businesses benefit from leadership turnover in healthcare, from both planned retirements as well as organizations focused on accelerating their growth, transformation, and technology strategies. Similar to the technology and process improvements made in our Nurse and Allied businesses, our locums business is in the middle of its own growth acceleration program, targeting year-over-year revenue growth in 2027. Our teams have already begun executing organizational and process improvement efforts that have energized the team, with larger technology enhancements rolling out in the coming months. For the fourth quarter, we project Physician and Leadership Solutions revenue to be down 5%-7% year over year. Third-quarter revenue for Technology and Workforce Solutions was $86 million, down 9% year over year and modestly better than our expectations. Language services revenue was $69 million, down 8% year over year and down less than 1% sequentially.
Minutes were up slightly year over year, while pricing was down 9%. VMS revenue was $15 million, lower by 11% year over year, though flat sequentially. Segment gross margin reflected the cost pressure we anticipated due to renegotiated language services contracts hitting in advance of completing the rollout of our lower-cost service model. Our global interpreter capacity will take a step higher in the first half of 2027, which should enable us to recover gross margin. We are continuing to empower WorkWise, our data technology and workforce optimization platform, while expanding our relationships across the AMN solution set. We continue to drive innovation in our Passport app for healthcare professionals, and we have enhanced its capabilities. One example is natural language job search, which is already having a positive impact on supply.
These efforts are designed to improve outcomes for clients and healthcare professionals and to support more durable, profitable growth over time. As we broaden our scope with advisory and AI innovation, we also expect the market opportunity for total talent solutions to expand. AMN has improved execution and recruiter productivity, broadened access to market segments, advanced our technology enablement, and demonstrated our ability to perform at scale. These capabilities are helping our clients manage their workforce more strategically, which we expect to become increasingly important to our success in the long run. Our teams are leading the way in the industry, simultaneously delivering great performance and innovative solutions for our healthcare professionals and clients. I will turn over the call to Brian for more details about our results and outlook.
Thank you, Cary. I'd like to expand on our third-quarter financial results published this afternoon. Consolidated third-quarter revenue of $717 million grew 13% year over year and 7% sequentially. Revenue was nearly 10% above the upper end of our guidance range, with the upside coming from strong performance in travel nurse and allied, along with higher labor disruption revenue. Our third-quarter guidance assumed $7 million of labor disruption revenue, compared with $59 million recognized in the quarter. The additional revenue consisted almost entirely of reserve adjustments associated with prior labor disruption events. Reported gross margin was 31.9%, 440 basis points above the top end of guidance. The higher margin resulted from the labor disruption reserve adjustments, which positively impacted gross margin by 520 basis points. Third-quarter net income was $33 million, compared to $29 million in the prior year period and $21 million in the prior quarter.
Adjusted EBITDA was $94 million, or 13% of revenue. Adjusted EPS was $1.16. Consolidated SG&A expense in the quarter were $149 million. Adjusted SG&A, excluding certain items, was $138 million, up 7% compared to the prior year, driven primarily by higher professional liability-related costs and changes to the allowance for credit losses. The Nurse and Allied segment reported revenue of $460 million, with a 30.9% gross margin and 17.5% segment operating margin. The labor disruption reserve adjustments favorably impacted the segment gross margin by 860 basis points and the segment operating margin by 1,030 basis points. Segment revenue, excluding labor disruption activity, increased 15% year-over-year, demonstrating strong execution in travel nurse and allied on higher demand. Travel nurse volume increased 21% year-over-year, while allied volume increased 12%. International nurse also experienced growth during the quarter, with revenue increasing 32% year-over-year.
However, we are expecting international volume to decline sequentially starting in Q4 until embassy visa appointments resume with some level of normalcy. Nurse and allied average bill rate was flat year-over-year, while average hours increased approximately 1%. For Physician and Leadership Solutions, revenue of $171 million was up 4% sequentially and down 4% year-over-year, while locum tenens revenue was $138 million, up 6% sequentially and down 5% over prior year. The sequential growth included a 3% increase in days filled volume. In our Technology and Workforce Solutions segment, revenue of $86 million was down 9% year-over-year and 1% sequentially. Segment trends continue to reflect pricing pressure and a dynamic operating environment for language services and client-specific utilization trends in the VMS business. Language services revenue was down 1% sequentially. Minutes increased 1% sequentially and were up slightly year-over-year. Pricing declined 1% sequentially and 9% year-over-year.
FULL TRANSCRIPT
Continue the full translated transcript in StockNow.
Log in to unlock every statement, the English original, and speaker-by-speaker history.
Log in for the full transcriptCall participants
12 people spoke on this call — only 2 are shown here.
PARTICIPANT LIST
View participant details in StockNow.
Log in to see executives and analysts, their roles, and complete speaking history.
Log in to view all participantsKeep exploring
